Diagnosis | Medibuddy
5th June 2025

Diagnosis

LcSSc and dcSSc both show the same signs and symptoms, but the skin distribution and course of the disease is different. Two thirds of patients with scleroderma have dcSSc, which has widespread skin involvement including proximal limbs. This is often rapidly progressive, has significant internal organ involvement and has a worse prognosis. One third of patients with scleroderma have lcSSc, where the sclerosis is limited to the digits, face and distal limbs (does not spread further than elbows or knees). It has a slower progression and less organ involvement, but carries a risk of pulmonary artery hypertension. Up to 20% of patients have an overlap syndrome with another connective tissue disease.

Systemic features

  • Gastrointestinal: dysmotility, gastroesophageal reflux (GORD), dysphagia, bloating, nausea and vomiting, alternating diarrhoea/constipation
  • Cardiopulmonary: interstitial lung disease (ILD), pulmonary artery hypertension, cardiomyopathy
  • Renal dysfunction: patients may present with abrupt onset of moderate/marked hypertension, which is a sign of scleroderma renal crisis 
  • Musculoskeletal: friction rubs over joints and tendons, synovitis, weakness and limited movement causing contractures
  • Ophthalmological: tight eyelids, reduced tear secretion, retinopathy
  • Fatigue, arthralgia, myalgia 
  • Sicca symptoms and Sjogren syndrome

Cutaneous features

Though the previous name, CREST syndrome, of lcSSc is no longer used, it remains a useful mnemonic to remember the key features:

  • Calcinosis
  • Raynaud’s phenomenon
  • (O)esophageal dysmotility
  • Sclerodactyly 
  • Telangiectasia
Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.